MON002: Clinical Trials

1 trial of MON002, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow MON002: new trials by email Literature Review of MON002 trials Research Report on MON002

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19
MON002 - Pulmonary Fibrosis, Interstitial Lung Disease
Phase 1 / Phase 2UnknownGuy's and St Thomas' NHS Foundation Trust52021-03-082021-03-18

Conditions studied

COVID-19 (1)  ·  Lung Diseases, Interstitial (1)  ·  Pulmonary Fibrosis (1)

Sponsors

Guy's and St Thomas' NHS Foundation Trust (1)

Countries

United Kingdom (1)

Top investigators

Ashish Patel, PhD FRCS (1)  ·  Bijan Modarai, PhD FRCS (1)